March 30, 2007 - According to the latest findings of the New York Early Lung Cancer Action Project, published in the April issue of the journal Radiology, annual computed tomography (CT) screenings identify a high proportion of patients with early-stage lung cancer.
According to the study, the estimated cure rate for lung cancer in the absence of screening is approximately five percent, but increases significantly when the cancer is diagnosed and treated at its earliest stage.
March 24, 2026 — MARS Bioimaging, a New Zealand–headquartered medical device company, has received U.S. Food and Drug ...
March 25, 2026 
March 23, 2026 — Samsung Medison hsa announced that its U.S. medical imaging businesses, previously operating as ...
March 23, 2026 
March 10, 2026 — QT Imaging Holdings has received U.S. Food and Drug Administration (FDA) 510(k) clearance for an ...
March 13, 2026 
March 11, 2026 — Noah Medical has announced the publication of the MATCH 2 study in the international, peer-reviewed ...
March 12, 2026 
March 5, 2026 — At ECR 2026, Royal Philips introduced Rembra, its next-generation radiology CT system designed for the ...
March 09, 2026 
Once considered an adjunct brain cancer therapy and a last-resort treatment, noninvasive radiosurgery has evolved ...
March 09, 2026 
March 2, 2026 — RadNet, Inc. has acquired Gleamer SAS, a radiology AI company based in Paris, France. Gleamer will be ...
March 03, 2026 
March 2, 2026 — Esaote Group will officially launch the new MyLab E85 and MyLab C30 GTS Edition ultrasound systems at ...
March 02, 2026 
Feb. 26, 2026 — DeepHealth, Inc., a provider of AI-powered health informatics and a wholly owned subsidiary of RadNet ...
February 27, 2026 
Feb. 9, 2026 — MRIguidance, a MedTech company developing BoneMRI, a radiation-free bone imaging solution, has appointed ...
February 09, 2026 